EU Action on Dementia
Since Alzheimer Europe presented its political priorities embedded in the "Paris Declaration" in 2006, a series of European developments have put dementia on the European agenda.
Thanks to the combined efforts of Alzheimer Europe, its members and the political support of the Members of the European Parliament as well of national policy makers, EU action on dementia has become a reality.
Date | Milestone |
|
| 2018 | European Parliament Written Question on the dismantling of the Commission Expert Group on Dementia |
|
| 2016 | Launch of 2nd Joint Action on Dementia |
|
| 2015 | ||
| 2015 | EPSCO Council adopts Luxembourg EU Presidency conclusions, with an emphasis on supporting people with dementia |
|
| 2014-2024 | Launch of "IMI 2" by the Innovative Medicines Initiative Neurodegenerative diseases and age-associated diseases are among the priorities of the Strategic Research Agenda. IMI (2) aims at reaching a 30% better success rate in clinical trials of priority medicines identified by the WHO; clinical proof of concept in immunological, respiratory, neurological and neurodegenerative diseases in just five years; new and approved diagnostic markers for four of these diseases and at least two new medicines which could either be new antibiotics or new therapies for Alzheimer’s disease. |
|
| 6 May 2014 | ||
| March 2014 | One of the thematic priorities includes ‘support cooperation and networking in the Union in relation to preventing and improving the response to chronic diseases including cancer, age-related diseases and neurodegenerative diseases, by sharing knowledge, good practices and developing joint activities on prevention, early detection and management (including health literacy and self management)’. |
|
| 2014-2020 | Launch of Horizon 2020, the European Commission Research and Innovation Programme. Horizon 2020 will cover societal challenges such as health, demographic change and well-being. Research & Innovation supported by this programme will improve our understanding of the causes and mechanisms underlying health, healthy ageing and disease; improve our ability to monitor health and to prevent, detect, treat and manage disease; support older persons to remain active and healthy; and test and demonstrate new models and tools for health and care delivery. http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing http://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020 |
|
| 28 March 2013 | Presentation of the ALCOVE project results, recommendations and anti-psychotic toolbox www.alcove-project.eu/images/pdf/triptico-alcove.pdf www.alcove-project.eu/images/pdf/ALCOVE_SYNTHESIS_REPORT_VF.pdf |
|
| 7 February 2012 | ||
| 7 November 2011 | ||
| 2011 | Launch of ALCOVE, the EU Joint Action on Dementia (2011-2013) |
|
| 19 January 2011 | European Parliament Resolution on a European Initiative on Alzheimer’s disease and other dementias |
|
| 9 December 2010 | European Parliament Report on a European initiative on Alzheimer’s disease and other dementias |
|
| 25 November 2010 | ||
| 10 April 2010 | ||
| March 2010 | ||
| 9 December 2009 | ||
| 1 December 2009 | Council of Ministers issues conclusions on "Dignified ageing" |
|
| 15-16 September 2009 | Swedish EU presidency holds conference on "Healthy and Dignified Ageing" |
|
| 22 July 2009 | ||
| 6 February 2009 | ||
| 17 December 2008 | ||
| 30-31 October 2008 | French Presidency of the European Union organises two-day conference on the fight against Alzheimer's disease |
| 2 July 2008 | |
| 15 February 2008 | Innovative Medicines Initiative (IMI) IMI Research Agenda includes the ‘Improved Predictivity of Efficacy Evaluation for brain disorders’, and more specifically, in the field of dementia : the identification and validation of pre-symptomatic and surrogate markers for disease progression, the development of model systems that translate to human pathology and are predictive of clinical efficacy, better understanding of disease mechanisms for improved target selection |
| 20 December 2007 | |
| 2007-2013 | European Commission's Research Programe - FP7(Framework Programme 7) emphasized collaborative research with a specific sub activity on "Research on the brain and related diseases, human development and ageing". Particular emphasis was placed on translational research, for bringing knowledge from bench to bedside and for development of new drug targets. |
| 23 October 2007 | European Commission White PaperCOM(2007) 630 final “Together for Health: A Strategic Approach for the EU 2008- 2013” developing the EU Health Strategy also identifies the better understanding of neurodegenerative diseases such as Alzheimer's as important needs to address. |
| 2007 |
Last Updated: Friday 18 May 2018
